Integrated Quantitative Investments LLC purchased a new stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 48,941 shares of the company's stock, valued at approximately $1,028,000. Integrated Quantitative Investments LLC owned 0.12% of Phibro Animal Health at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. Hussman Strategic Advisors Inc. purchased a new position in shares of Phibro Animal Health during the 4th quarter worth approximately $2,205,000. Jacobs Levy Equity Management Inc. grew its stake in Phibro Animal Health by 116.6% in the third quarter. Jacobs Levy Equity Management Inc. now owns 192,255 shares of the company's stock worth $4,330,000 after purchasing an additional 103,491 shares during the period. Alliancebernstein L.P. raised its holdings in Phibro Animal Health by 357.1% in the fourth quarter. Alliancebernstein L.P. now owns 130,000 shares of the company's stock worth $2,730,000 after purchasing an additional 101,560 shares in the last quarter. Prudential Financial Inc. lifted its position in Phibro Animal Health by 405.8% during the fourth quarter. Prudential Financial Inc. now owns 120,655 shares of the company's stock valued at $2,534,000 after buying an additional 96,800 shares during the period. Finally, American Century Companies Inc. lifted its position in Phibro Animal Health by 18.0% during the fourth quarter. American Century Companies Inc. now owns 635,599 shares of the company's stock valued at $13,348,000 after buying an additional 96,787 shares during the period. 99.34% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several brokerages recently issued reports on PAHC. Barclays increased their price target on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a research note on Monday, February 10th. StockNews.com lowered shares of Phibro Animal Health from a "buy" rating to a "hold" rating in a report on Tuesday, March 25th. Finally, Morgan Stanley upped their price target on Phibro Animal Health from $20.00 to $25.00 and gave the stock an "equal weight" rating in a research note on Tuesday, December 17th. Two analysts have rated the stock with a sell rating and three have issued a hold rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $21.00.
View Our Latest Stock Report on PAHC
Phibro Animal Health Stock Down 1.5 %
Shares of NASDAQ:PAHC traded down $0.28 during trading on Wednesday, reaching $17.61. 113,678 shares of the stock traded hands, compared to its average volume of 246,770. Phibro Animal Health Co. has a 52-week low of $12.30 and a 52-week high of $26.55. The stock has a market cap of $713.06 million, a P/E ratio of 36.94, a price-to-earnings-growth ratio of 0.45 and a beta of 0.63. The stock has a 50-day moving average of $22.48 and a two-hundred day moving average of $22.56. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its earnings results on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. As a group, sell-side analysts expect that Phibro Animal Health Co. will post 1.95 earnings per share for the current fiscal year.
Phibro Animal Health Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th were issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 2.73%. The ex-dividend date of this dividend was Wednesday, March 5th. Phibro Animal Health's dividend payout ratio is currently 100.00%.
About Phibro Animal Health
(
Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Featured Stories
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
